These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35217400)

  • 41. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy.
    Hsieh RC; Chou YC; Hung CY; Lee LY; Venkatesulu BP; Huang SF; Liao CT; Cheng NM; Wang HM; Wu CE; Kang CJ; Chen MF; Cheng YF; Yeh KY; Wang CH; Chou WC; Lin CY
    Radiother Oncol; 2023 Nov; 188():109891. PubMed ID: 37659659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
    Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA
    Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities.
    Faisal M; Abbas T; Khaleeq U; Adeel M; Anwer AW; Hussain R; Jamshed A
    Cureus; 2017 May; 9(5):e1203. PubMed ID: 28580200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
    Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
    Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
    Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer of retromolar trigone: long-term radiation therapy outcome.
    Huang CJ; Chao KS; Tsai J; Simpson JR; Haughey B; Spector GJ; Sessions DG
    Head Neck; 2001 Sep; 23(9):758-63. PubMed ID: 11505486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
    Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
    Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative radiotherapy may not be necessary for locally advanced head and neck squamous cell carcinoma: a case-match multicentre study.
    Ren ZH; Lei JS; Yang ZM; Zhang S; Yu JJ; Wu HJ
    BMC Oral Health; 2022 Jun; 22(1):253. PubMed ID: 35751079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival outcomes of patients with subglottic squamous cell carcinoma : a study of the National Cancer Database.
    Shi LL; McMullen C; Vorwald K; Nichols AC; MacNeil SD; Wadsworth JT; Chung CH; Wang X; Patel KB
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4923-4932. PubMed ID: 33646344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features.
    Katz O; Nachalon Y; Hilly O; Shpitzer T; Bachar G; Limon D; Popovtzer A
    Head Neck; 2017 Jan; 39(1):147-150. PubMed ID: 27507221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.